Childhood Myopia (nearsightedness) is increasing. Less time spent outside and more time spent in front of screens is causing an earlier and more rapid progression of Myopia. Increased myopia results in an increased lifetime risk for retinal detachment, macular degeneration, glaucoma, and cataracts. Children are at highest risk for increasing their myopia until age 18 with the most progression until age 11. Fortunatelly, recent studies have shown that myopic progression can be slowed through various therapies.
Dr. Dietrich focuses on two types of therapies; Prescription opthalmic drops and soft contact lens therapy. Call today to schedule an appointment to discuss treatment options!
Diluted Atropine Therapy:
Patients using this therapy option insert one drop of diluted Atropine into each eye before bed or as otherwise instructed by your doctor. This option is ideal for patients who are not interested in wearing contact lenses. While this therapy uses Atropine, a drop typically used to dilate pupils, diluted Atropine does not have the same effects as full-strength Atropine. This method of therapy has shown up to a 59% reduction in myopia progression in studies.
Soft Contact Lens Therapy:
Patients using this therapy option wear specifically designed contact lenses daily. These lenses keep your distance vison clear, while controlling how specific light rays that impact myopia progression, focus on the back of your eyes. This option is ideal for patients who do not like eye drops and like the idea of wearing comfortable soft contact lenses daily. This method of therapy has shown up to a 49% reduction in myopia progression in studies.